Patents for A61P 33 - Antiparasitic agents (21,787)
08/1999
08/31/1999US5945316 From optically active or racemic amino acids and 2-hydroxycarboxylic acids
08/31/1999US5945302 Nucleotide sequences that code for proteins for use in recombinant technology, induce production of cytokines, activate cell differentiation, stimulate and suppress immune responses, and therapy for autoimmune diseases
08/27/1999CA2242794A1 2,4-bis[(4-aminidino)phenyl]furans as anti-pneumocystis carini agents
08/26/1999WO1999029714A3 Organic chemical compounds and method for producing the same
08/24/1999US5942413 Polynucleotide fragment that codes an antigen from parasitic worms; antihelmintics
08/24/1999US5942403 Compounds and methods for the detection of t. cruzi infection
08/24/1999US5942218 A solution comprising polyhexamethylene biguanide; wound treatment material for both prophylaxis and treatment of infections such as an antimicrobial, antiviral, anti-parasitic material
08/19/1999WO1999001416A3 1-amino-alkylcyclohexane nmda receptor antagonists
08/18/1999EP0935465A1 Novel substituted imidazole compounds
08/18/1999EP0935462A1 Photopheresis treatment of leukocytes
08/17/1999US5939399 Polyene antibiotics, 3874 H1 to H6, processes for their preparation and use
08/17/1999CA2183247C Antimalarial korupensamines and pharmaceutical compositions and medical uses thereof
08/12/1999WO1999040108A1 New compound
08/12/1999WO1999022761A9 Conjugate heat shock protein-binding peptides
08/12/1999CA2320416A1 New compound
08/11/1999EP0933998A1 Method for the prevention of the reinfestation of warm-blooded animals by ectoparasites
08/11/1999EP0646132B1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use
08/11/1999CN1225590A Peptides with increased binding affinity for HLA molecules
08/11/1999CN1225579A Granulates of hexalhydropyrazine derivatives which can be administered orally
08/11/1999CN1225360A Substituted imidazolidine derivatives, their prepn., their use and pharmaceutical prepn. comprising them
08/10/1999US5935814 G-protein coupled receptor family polypeptides, referred to as hfgan72y, altered nucleic acid seqences encoding it and recombinant materials and methods for its production; use in design of protocols and treatment of various infections
08/10/1999US5935583 A vaccine strain of giardia which is cultured in media containing bile so as to produce a toxin in vitro for preventing or treating intestinal protozoal infections in an animal
08/10/1999US5935572 Composition containing protease separate from glycosidase for removing nits in treating lice infestation
08/04/1999EP0933363A1 Parasiticidal pyrazoles
08/04/1999EP0933026A1 Compounds for protecting animals and humans against attack and infestation by arthropod parasites
08/04/1999EP0932420A1 Drug delivery using terminal complement components
08/04/1999EP0740653B1 Hydroxamic acid derivatives as metalloproteinase inhibitors
08/04/1999EP0538437B1 Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
08/03/1999US5932591 C3 substituted trioxanes useful as antiparasitic drugs
08/03/1999US5932225 Vaccine comprising eimeria spp. gametocyte antigen
08/03/1999US5932220 Lyme disease; using a peptide
08/03/1999CA2171871C Stable solvates of avermectin compounds
07/1999
07/30/1999CA2260431A1 1,4-diaryl-3-fluoro-2-butene compounds for protecting animals and humans against attack and infestation by arthropod parasites
07/29/1999WO1999037322A1 Method of using il-11 to enhance cell mediated immunity for treating various viral and parasitic infections and cancer
07/29/1999WO1999037289A1 Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
07/29/1999WO1999012968A3 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
07/29/1999WO1999012951A9 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
07/29/1999CA2318382A1 Method of using il-11 to enhance cell mediated immunity for treating various viral and parasitic infections and cancer
07/28/1999EP0931082A1 Nodulisporic acid derivatives
07/28/1999EP0930891A1 Oral administration of chicken yolk antibodies to treat disease
07/27/1999US5928901 Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by P. falciparum in hepatocytes and compositions containing them
07/27/1999US5928636 Injecting synergistic mixture to treat herpes, hepatitis, papilloma and human t-cell leukemia/lymphoma viruses; administering as bactericide, parasiticide, and/or antiprotozoa agent
07/22/1999WO1999036069A1 Il-8 receptor antagonists
07/22/1999WO1999027793A3 An antimicrobial composition
07/22/1999CA2318195A1 Il-8 receptor antagonists
07/21/1999EP0930077A1 Cyclodextrin compositions comprising an avermectin or a milbemycin derivative
07/21/1999EP0929677A2 Method for producing recombinants intended for use in a complete malaria antigene gp190/msp1
07/21/1999EP0929578A1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
07/21/1999EP0929571A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
07/21/1999EP0929568A2 Pharmaceutical compositions for the treatment of immune disorders
07/21/1999EP0929555A1 25-methylene and 24,25-epoxy marcfortines and paraherquamides
07/20/1999US5925772 Cysteine protease inhibitors containing heterocyclic leaving groups
07/20/1999US5925653 Substituted pyridines and pyrimidines processes for their preparation and their use as pesticides and fungicides
07/20/1999US5925568 It is also useful to be able to harvest haematopoietic cells prior to chemotherapy or radiotherapy, thus protecting them from the effects of this therapy; after therapy, the cells can be returned to the patient.
07/20/1999US5925369 Bis alkanoyl esters of carnitine having bactericidal, fungicidal and antiprotozoal activity
07/20/1999US5925347 Viral vector vaccines comprising nucleic acids encoding eimeria proteins for poultry vaccination against coccidiosis
07/20/1999CA2259699A1 Cyclodextrin compositions
07/15/1999WO1999035247A1 Novel therapeutic uses of heterologous superoxide dismutase (hsd), and method for selecting said hsd
07/15/1999WO1999035157A1 Novel erythromycin derivatives
07/15/1999WO1999035156A1 Novel macrolides
07/14/1999CN1222936A Recombinant protein containing c-terminal fragment of plasmodium MSP-1
07/13/1999US5922761 Methods for in vivo reduction of iron levels and compositions useful therefor
07/13/1999US5922740 Antiinflammatory agents
07/13/1999US5922329 Immunity against giardia from vaccine from isolation of exotoxin
07/08/1999WO1999033868A2 Human papillomavirus vaccine
07/08/1999WO1999033829A1 Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them
07/08/1999WO1999033811A1 Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof
07/08/1999WO1999033488A2 Adjuvanted vaccine formulation
07/08/1999WO1999014231A3 Bifidus stimulating peptides and its uses
07/08/1999WO1999004810A3 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment
07/08/1999CA2315276A1 Human papillomavirus vaccine
07/08/1999CA2313487A1 Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof
07/07/1999EP0927183A1 Spirocyclic metalloprotease inhibitors
07/07/1999CN1043996C Antiparasitic agents and its prepn. method and use
07/06/1999US5919789 Xanthines and their therapeutic use
07/01/1999WO1999032648A1 Recombinant rhabdovirus containing a heterologous fusion protein
07/01/1999WO1999032111A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
07/01/1999WO1999032088A1 Aqueous insecticidal pour-on formulation
07/01/1999CA2315720A1 Inhibition of p38 kinase activity using substituted heterocyclic ureas
06/1999
06/30/1999EP0925308A2 Compositions and methods for treating infections using analogues of indolicidin
06/30/1999EP0925059A1 Protein-lipid vesicles and autogenous vaccine comprising the same
06/29/1999US5916887 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
06/29/1999US5916572 Chagas' disease
06/29/1999CA1340612C Cell specific cytotoxic agents derived from diphtheria toxin
06/24/1999WO1999031246A1 Compounds and methods for the detection and prevention of t. cruzi infection
06/24/1999WO1999030720A1 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
06/24/1999WO1999007728A3 Linear peptides derived from antibiotic peptides, preparation and use for vectoring active substances
06/24/1999WO1997030158A9 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
06/23/1999CN1043768C Avermectin derivative, its preparing method and use, and drug composition containing said derivative
06/17/1999WO1999029714A2 Organic chemical compounds and method for producing the same
06/17/1999WO1999029693A1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
06/17/1999WO1999029341A2 Methods for enhancement of protective immume responses employing leishmania polypeptides
06/17/1999WO1999029316A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
06/17/1999WO1998056919A3 Methods and reagents for vaccination which generate a cd8 t cell immune response
06/16/1999EP0921816A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
06/16/1999EP0804411A4 Synthetic polyunsaturated fatty acid analogues
06/16/1999CN1219420A External protection medicine for preventing schistosoma miracidium infection
06/16/1999CN1219413A Chinese medicinal preparation for curing eczematous dermitis of young pigs
06/15/1999US5912337 Parasitic helminth p22U proteins
06/15/1999US5911991 Malarial binding site in duffy blood group protein